In the present study, for the first time, we identified CCNB1 as a downstream target of WDR4 in HCC and demonstrated that CCNB1 reduces DNA damage and promotes PI3K/AKT phosphorylation and P53 ubiquitination. This evidence concerns the gene TP53 and hepatocellular carcinoma.